Clauser Noah
SEC insider (Form 3/4/5 filer). CIK 0001796466. Chief Financial Officer at Astria Therapeutics, Inc. (ATXS). 3 reported Form 4/5 transactions since Sep 2024; latest on Jan 23, 2026. Located in BOSTON, MA.
Companies Clauser Noah has filed insider reports for
- Astria Therapeutics, Inc. (ATXS): Officer, Chief Financial Officer
Clauser Noah
CIK: 0001796466
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)2 (66.7%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ATXS
Astria Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jan 23, 2026ATXS
Astria Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
55K shares- - Jan 23, 2026ATXS
Astria Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
262.5K shares- - Mar 21, 2025ATXS
Astria Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
262.5K shares-
1-3 of 3 transactions